Celldom, Inc.

Celldom, Inc. is a biotechnology startup with a mission to find and study cells that make diseases incurable. Founded in 2016 and based in the United States, Celldom is revolutionizing single cell analysis technology. Their slogan "Find and study cells that make diseases incurable" captures the essence of their work. The company's flagship product, cloneXplorer, and proprietary nanowell plates integrate phenotypic and genomic data at a massive scale, allowing for the identification and characterization of rare cells crucial to biological pathways and disease. Their technology enables the analysis of up to 100,000s of cells per experiment, offering a significant advancement in research, drug discovery, and drug development. Celldom's focus on applications in oncology, immunology, and stem cell biology showcases the potential impact of their technology on critical medical fields. The company recently secured a Seed Round investment on 12 April 2021, with backing from notable investors such as TSVC and Corning. With a strong emphasis on illuminating diversity in cell populations, Celldom is poised to make a significant contribution to advancing the understanding and treatment of diseases. For more information, visit their website at www.celldom.com and follow their growth on Twitter at @celldominc.